ECSS
BMY icon

Eurizon Capital SGR SpA’s Bristol-Myers Squibb BMY Stock Holding History

Eurizon Capital SGR SpA’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71M Sell
1,230,296
-92,498
-7% -$5.31M 0.19% 99
2026
Q1 		$80.2M Sell
1,322,794
-203,524
-13% -$11.9M 0.25% 85
2025
Q4 		$82.4M Buy
+1,526,318
New +$73.4M 0.26% 84

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Eurizon Capital SGR SpA's BMY Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Bristol-Myers Squibb (BMY) stake by 7% in Q2 2026, selling an estimated $5.31M and leaving 1,230,296 shares worth $71M. The position accounts for 0.19% of the portfolio, ranked #99.

Eurizon Capital SGR SpA first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $82.4M in Q4 2025. 2,505 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Eurizon Capital SGR SpA held 1,230,296 shares of Bristol-Myers Squibb worth $71M as of Q2 2026.
  • Eurizon Capital SGR SpA sold 92,498 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.31M.
  • Bristol-Myers Squibb made up 0.19% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #99 holding.
  • Eurizon Capital SGR SpA first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Bristol-Myers Squibb position peaked at $82.4M in Q4 2025.
  • 2,505 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.